Oxford Genome Sciences Advances on Amgen Deal

Oxford Genome Sciences has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech firms.
OutsourcingPharma